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IT has long been recognized that a reliable method for the production of
adenocarcinoma of the animal stomach would greatly facilitate research into the
etiology, diagnosis and therapy of this form of cancer. The poor prognosis of
gastric cancer in man makes these studies highly desirable. The difficulties in
producing carcinoma of the glandular stomach in animals has been described in
several comprehensive papers that have appeared during the past two decades
(Beck, 1946; Klein and Palmer, 1941; Stewart, Snell and Hare, 1958), as well
as in many others.
Until the work ofMorris, Wagner, Ray, Snell and Stewart (1961) no methodfor
the experimental induction of adenocarcinoma of the animal stomach by oral
administration of carcinogens had been successful.
It appeared reasonable to the early workers that a potent epithelial carcino-
gen such as methylcholanthrene or benzopyrene would, on administration per os,
attack the gastric mucosa and produce stomach cancer. Only squamous fore-
stomach tumors, howe-ver, were obtained. Ray and Jung (1951) reasoned that
because the glandular tissue was protected against contact carcinogenesis by the
flow of mucus and other secretions, no effective attack could take place. Efforts
to penetrate or destroy the mucus barrier by Setala and Ermala (1951) and by
Richardson (1956) yielded doubtful results. It seemed to us that if we were to
be successful we would have to find a carcinogen that would be absorbed into the
circulation and be secreted into the lumen of the stomach. In passage it would
come in intimate contact with the immature glandular cells which should be most
susceptible to attack (Ray, Cambel, Jung, Peters and Woislawski, 1953).
The work on gastric secretion in the dog by Dawson and Ivy, (1925) and by
Ingraham and Visscher (1935) showed that basic dyes appear in considerable
concentration in the stomach when injected intravenously. We were able to
extend this observation to rats (Ray and Peters, 1951) and to the intraperitoneal
route of administration (Cambel, Breidenbach and Ray, 1954).
If the basicity of a compound facilitates its secretion into the stomach, the
ionization constant (pK',) should be related to the extent of secretion (Ray and
Jung, 1951). This, within certain limitations, proved to be true (Ray and Pease,
1957). One limitation was that the dye must not be metabolized to a substance
of different basicity before its passage through the stomach wall. It is possible
that the diffusion coefficient of the substance may also be of significance.
Our choice of a basic carcinogen first fell on 2-aminofluorene, since it seemed to
be the most versatile basic carcinogen known. Using the radioactive derivativeGASTRIC CARCINOGENS
of Ray and Geiser (1950; cf. 1949), Weisburger, Weisburger and Morris (1951)
showed that when acetylated aminofluorene was administered to the rat it was
rapidly deacetylated. Other work by Morris, Dubnik and Johnson (1950) showed
that aminofluorene and its N-acetyl derivative were equally carcinogenic. It
seemed possible, nevertheless, that a variation of N-acyl groups, and other sub-
stituents, might influence the degree of carcinogenicity. This proved to be the
case (Morris, Velat, Wagner, Dahlgard and Ray, 1960) and it was possible, to a
certain extent, to relate the degree of carcinogenicity to the ease of hydrolysis of
the N-acyl group (Argus and Ray, 1959).
Not only was the degree of carcinogenicity altered, but the site of attack was
often shifted. For example, using N-2-fluorenylsuccinamic acid, it was found that
carcinogenic attack on the mammary gland was almost completely eliminated
in female rats, while a substantial number of liver tumours developed (Morris,
Velat, Wagner, Dahlgard and Ray, 1960). The N-2-fluorenylphthalamic acid
of Argus and Ray (1959) gave rise to the Morris hepatoma 5123 (Morris and
Wagner, 1961), which varied considerably in enzymatic activity from most other
hepatomas. Unfortunately, none of the many sites attacked by 2-aminofluorene
derivatives was the glandular stomach.
On re-examining the evidence, it seemed that the reason for failure lay in the
fact that aminofluorene was not basic enough. It was decided to increase the
basicity by adding another amino group to produce 2, 7-diacetylaminofluorene
(also called N, N'-2, 7-fluorenylenebisacetamide). The ionization constants of
2-aminofluorene and 2, 7-diaminofluorene were measured recently by Grantham,
Weisburger and Weisburger (1961). In 70 per cent ethanol 2-aminofluorene has
a pK'a of 4-31, while 2, 7-diaminofluorene, which has two basic groups, gives pK'a
4'97, andpK"~ 3.5. Thus, as expected, 2, 7-diaminofluorene is considerably more
basic than 2-aminofluorene.
When fed to 47 Buffalo and AXC strain rats for a maximum of 47 weeks, 2, 7-
diacetylaminofluorene produced four carcinomas ofthe glandular stomach (among
many other tumours), one in the fundus and three in the pyloric region (Morris,
Wagner, Ray, Snell and Stewart, 1961). The effect may have been due to the
greater carcinogenicity of the 2, 7-compound which was evident by greater pro-
duction of lung, submaxillary gland, intestinal, uterine and auditory canal tum-
ours. There was also a larger number of leukemias. On the other hand, more
mammary gland tumours were obtained with the 2-amino compound, as well as an
equal or slightly greater number of liver tumours. It was of interest, then, to
determine ifthe more basic 2, 7-diamino compound is indeed secreted more readily
than the 2-amino.
MATERIALS AND METHODS
Carcinogens
One gram each of 2-nitrofluorene and 2, 7-dinitrofluorene was treated with
15 curies of tritium gas at 27° and 0.39 atmosphere for two weeks. The specific
activity ofthe mononitro compound was 0.51 mc/mg. The specific activity ofthe
2, 7-dinitrofluorene was 0-95 mc/mg. The substances were reduced catalytically with hydrogen and platinum, acetylated and recrystallized until the mother
liquor showed a constant activity. The analysis was by the method ofWilzbach,
Van Dyken and Kaplan (1954) using an ionization chamber and Cary No. 31
vibrating reed electrometer. By carrying out two reactions on the material it
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was possible to eliminate radioactive impurities. The radiation of amines tends
to produce large amounts of impurities that are difficult to separate. The nitro
compounds, however, are comparatively stable. The resulting acetylated
amines had rather low specific activities of 31-04 ,c/mg. for 2-acetylamino-
fluorene and 21.98 /tc/mg. for 2, 7-diacetylaminofluorene. This indicates that
the major amount of tritium activity had been concentrated at the reactive
methylene group in the 9-position. On reduction of the nitro groups this was
exchanged for hydrogen. It is ofinterest to note that before reduction the dinitro
compound had the greater activity. This agrees with the known greater activity
of the methylene group in disubstituted fluorenes. In addition, 2, 7-dinitro-
fluorene has one less nuclear hydrogen for permanent replacement by tritium.
Animals
Six male Sprague-Dawley rats weighing 450-550 g. were fasted for a 24 hr.
period, followed by intraperitoneal injections of Nembutal (15 mg./kg.). Further
anesthesia was induced by ether inhalation. The abdominal hair was shaved,
the skin swabbed with 70 per cent alcohol, and a 3-cm. mid-line incision made at
the level of the stomach. The gastro-intestinal tract immediately below the
pylorus was ligated to retain the secreted materials within the stomach. After
closing the incision the animals were allowed a 2-hr. rest period. They were
then divided into two groups, one receiving 4-5 mg. 139.7 /tc of labeled 2-acety-
laminofluorene in one ml. of 1 per cent methyl cellulose, the other, 4-5 mg, (98-9
,c) of labeled 2, 7-acetylaminofluorene per animal intraperitoneally. Four hours
later the animals were sacrificed, the esophagous ligated at its lower end, the stom-
ach and its contents were excised. The stomach and contents were separately
mixed with a solution of 1 per cent sodium hydroxide, 10 ml./g. and allowed to
stand for two days in the cold room. Following this the samples were autoclaved
for 30 minutes at 250° F at 18 lb./sq. in.
Individual samples, using 0*1 ml. of the stomach and its contents, were heated
in a sealed tube with 0.2 g. of nickel and 1 g. of zinc at 700° C. for 3 hr. in an
electric furnace. These samples were transferred to an ionization chamber for
analysis. The amount ofradioactivity was determined separately in the stomach
and in the contents.
RESULTS AND DISCUSSION
The data show (Table I) that 2, 7-diacetylaminofluorene is taken up by the
stomach wall to a greater extent (141 per cent) than is 2-acetylaminofluorene. On
TABLE I.-Radioactivity in Stomach Tissue and Contents*
2-Acetylaminofluorene-H3 2, 7-Diacetylaminofluorene-H3
----~ -A Ratios
lug. % lug. % 2,7-/2-
Stomach wall§ . 33-82/4500t 0-752 47-77/4500t 1-062 . 1-061/0.752=1-41
Stomach contents . 30.22/4500t 0.673 . 25-02/4500t 0 556 . 0 556/0.673=0 83
RSW_ 1.70
R SC
*Data in total jug. and per cent of dose per average animal.
t Total amount found/original dose.
+ Ratio of the two ratios, 1
- 41/0 - 83: stomach wall/stomach contents.
§ Average weight 3- 5 g. Three animals used for each compound.
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the other hand, only 83 per cent as much 2, 7- is found in the stomach contents.
The ratio between these two percentages is 170 per cent, which seems large
enough to indicate a real difference in the behaviour of the two compounds.
Preliminary experiments some years ago convinced us that 2-acetylamino-
fluorene was, indeed, secreted by the stomach of the rat (Ray, Cambel, Jung,
Peters and Woislawski, 1953) so this was no surprise. It was surprising, however,
to find the amount to be comparatively so great. Obviously, it is not the degree
of secretion that is important. It is probable that the proportion retained in
the stomach wall is the critical factor. Since, in carcinogenesis, these compounds
are fed for a prolonged period, it is possible that a considerable differential build-up
ofthe 2, 7- compound takes place. It has been well demonstrated by Weisburger
and Weisburger (1954) and Dyer and Morris (1956), and others, that protein
binding occurs between 2-acetylaminofluorene and the tissues of rats. Since
this seems to be a necessary first step in carcinogenesis it may well be that the
41 per cent increase in the stomach tissue added to the somewhat greater potency
of 2,7-diacetylaminofluorene was just sufficient to exceed the critical stage. It
is, of course, conceivable that the amount of 2, 7-diacetylaminofluorene localized
in the stomach wall is not sufficiently greater to be a deciding factor: the differ-
ence then would be attributed solely to the increased carcinogenicity of the 2,
7- compound. In either case the basicity ofthe compound seems to be a necessary
prerequisite and points the direction towards further investigation.
SUMMARY AND CONCLUSION
The secretion of 2-acetylaminofluorene and 2, 7-diacetylaminofluorene by the
stomach has been compared. The latter alone causes adenocarcinoma of the
stomach and 41 per cent more of the administered dose was found in the stomach
wall; some 17 per cent more of the former was found in the contents. Over a
period oftime the increased percentage taken up might result in a large differential
in the stomach tissue. On the other hand, the relative amount taken up may not
be significant and the carcinogenicity may be attributed entirely to the greater
potency of 2,-7-diacetylaminofluorene. The basic nature of the compounds in
any event enables them to reach the target area.
This research was supported by the National Institutes of Health Grant
C-1066.
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